GO:0045214 sarcomere organization: Assembly, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0045214 (sarcomere organization) describes the myofibril assembly process that organizes muscle actomyosin into sarcomeres, the repeating contractile units of a myofibril.
• Sarcomere organization is essential for muscle contraction, because the precise overlap of thick and thin filaments between Z discs determines force generation.
• The process is regulated by post-translational modifiers such as the SUMO system, which controls sarcomeric protein stability and assembly.
• Disrupted sarcomere organization is linked to hypertrophic cardiomyopathy, heart failure with preserved ejection fraction, and arrhythmogenesis.
• Key genes include MYH7, MYBPC3, TNNT2, ACTC1, FHOD3, and TTN, whose variants or loss of function alter sarcomere structure and function.
• CRISPR-based knockout, point-mutation, knock-in, and overexpression models enable causal testing of sarcomere genes in human stem cell-derived cardiomyocytes.
Description
Sarcomere organization (GO:0045214) is the biological process that assembles muscle actomyosin into sarcomeres, the repeating contractile units of a myofibril. This process is fundamental to muscle physiology because the sarcomere is the smallest force-generating unit of striated muscle, and its regular arrangement of thick and thin filaments between Z discs is required for coordinated contraction. Researchers study sarcomere organization to understand how mutations in sarcomeric genes cause cardiomyopathy and to develop models that recapitulate human cardiac disease in vitro. Recent work has shown that sarcomere organization is not a static structural event but a dynamic process regulated by post-translational modifications, including the SUMO system, and by signaling pathways that respond to metabolic stress. Human induced pluripotent stem cell-derived cardiomyocytes have become a powerful system for investigating sarcomere organization because they can be genetically edited and matured to display organized sarcomeres. This article integrates the QuickGO definition with verified PubMed literature to provide a research-grade overview of GO:0045214, its molecular players, disease relevance, and experimental approaches.
sarcomere organization At A Glance
| GO ID | GO:0045214 |
|---|---|
| GO term | sarcomere organization |
| Ontology | biological_process |
| Synonym | sarcomere alignment; sarcomere organisation |
| Major function | Assembly and organization of muscle actomyosin into sarcomeres, the repeating contractile units of myofibrils |
| Definition source | QuickGO definition: The myofibril assembly process that results in the organization of muscle actomyosin into sarcomeres |
| Related cellular structure | Sarcomere, composed of overlapping thick and thin filaments between Z discs |
| Key regulatory mechanism | SUMOylation and other post-translational modifications regulate sarcomeric protein assembly and stability |
| Disease relevance | Hypertrophic cardiomyopathy, heart failure with preserved ejection fraction, and arrhythmogenesis |
What Is GO:0045214?
GO:0045214 (sarcomere organization) is defined as the myofibril assembly process that results in the organization of muscle actomyosin into sarcomeres. The sarcomere is the repeating unit of a myofibril in a muscle cell, composed of an array of overlapping thick and thin filaments between two adjacent Z discs. In other words, it is the cellular process that builds and aligns the contractile machinery of muscle cells into regular, functional units.
Why Is sarcomere organization Important in Cell Biology?
Sarcomere organization is important because it directly determines the contractile capacity of striated muscle, and its disruption is a primary cause of inherited and acquired cardiomyopathies. The precise alignment of thick and thin filaments is required for efficient force transmission, and even subtle defects in sarcomere assembly can lead to compensatory hypertrophy, arrhythmias, and heart failure. Understanding GO:0045214 therefore has direct clinical implications for diagnosing and treating muscle diseases, and it provides a mechanistic framework for interpreting genetic variants in sarcomeric genes.
• Defines the structural basis of muscle contraction by organizing actomyosin into sarcomeres.
• Mutations in sarcomere genes are among the most common causes of hypertrophic cardiomyopathy.
• Altered sarcomere organization contributes to heart failure with preserved ejection fraction in obesity.
• Disrupted sarcomere organization can trigger arrhythmogenesis in transplanted human cardiomyocytes.
• SUMOylation regulates sarcomere assembly and protein quality control, linking post-translational modification to contractile function.
• FHOD3 deficiency impairs sarcomere organization and activates CaMKII signaling in human stem cell-derived cardiomyocytes.
• Advanced maturation of human cardiac tissue from pluripotent stem cells enables study of sarcomere organization in vitro.
• Sarcomere organization is a readout for cardiac tissue maturation and drug response.
• Genetic variants in sarcomere genes can be functionally tested using CRISPR-edited cardiomyocytes.
• Understanding sarcomere organization informs therapeutic strategies for cardiomyopathy and heart failure.
What Happens During sarcomere organization?
Assembly of thick and thin filaments
In simple terms: The cell builds the two main types of protein filaments that will form the sarcomere.
During sarcomere organization, myosin-based thick filaments and actin-based thin filaments are synthesized and assembled into ordered arrays. The molecular basis for this organization in vertebrate skeletal muscle involves the precise alignment of these filaments between Z discs, which is essential for contraction. This step requires the coordinated expression and folding of sarcomeric proteins, and it is regulated by post-translational modifications such as SUMOylation.
Formation of Z discs and sarcomere boundaries
In simple terms: The cell creates anchor points that define the ends of each sarcomere unit.
Z discs form the boundaries of each sarcomere and anchor the thin filaments. The organization of actomyosin into sarcomeres depends on the proper assembly of these Z-disc structures, which link the contractile apparatus to the cytoskeleton. Disruption of Z-disc components can lead to misalignment of filaments and impaired contractility.
Alignment and registration of sarcomeres
In simple terms: The newly built sarcomeres are lined up in a regular pattern so the muscle can contract efficiently.
Sarcomere organization includes the alignment of adjacent sarcomeres into myofibrils, ensuring that force is transmitted along the muscle cell. This alignment process is sensitive to genetic and metabolic perturbations; for example, severe obesity in human heart failure with preserved ejection fraction alters contractile protein function and organization. Advanced maturation of human cardiac tissue from pluripotent stem cells promotes this alignment in vitro.
Regulation by SUMOylation and signaling pathways
In simple terms: Chemical tags and signaling enzymes control how well the sarcomere is put together.
The SUMO system is a key regulator of sarcomere organization, controlling the stability and assembly of sarcomeric proteins. In addition, FHOD3 deficiency disrupts sarcomere organization and activates CaMKII signaling in human stem cell-derived cardiomyocytes, indicating that formin-mediated actin dynamics and calcium signaling intersect with sarcomere assembly. These regulatory layers ensure that sarcomere organization responds to developmental and stress cues.
Functional maturation and contractile integration
In simple terms: The finished sarcomeres start working together to produce a heartbeat or muscle movement.
Once sarcomeres are organized, they integrate into the contractile apparatus and begin generating force. Human cardiomyocytes derived from pluripotent stem cells can be matured to display organized sarcomeres and improved contractile function. Flexible nanoelectronics have revealed that arrhythmogenesis in transplanted human cardiomyocytes is associated with abnormalities in sarcomere organization and electrical coupling.
Key Genes Involved in GO:0045214 sarcomere organization
The following genes and proteins are central to sarcomere organization (GO:0045214) based on verified literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| MYH7 | Encodes beta-myosin heavy chain, a core thick filament protein | Mutations cause hypertrophic cardiomyopathy and alter sarcomere organization |
| MYBPC3 | Encodes cardiac myosin binding protein C, regulates thick filament assembly | Commonly mutated in hypertrophic cardiomyopathy; affects sarcomere structure |
| TNNT2 | Encodes cardiac troponin T, regulates thin filament activation | Mutations linked to cardiomyopathy and sarcomere disorganization |
| ACTC1 | Encodes cardiac actin, a major thin filament component | Variants affect sarcomere assembly and contractility |
| FHOD3 | Formin homology 2 domain containing 3, regulates actin filament organization | Deficiency disrupts sarcomere organization and activates CaMKII signaling |
| TTN | Encodes titin, a giant sarcomeric protein that provides elasticity and sarcomere alignment | Central to sarcomere organization and mechanosensing |
| MYL2 | Encodes regulatory myosin light chain | Modulates thick filament stability and contraction |
| MYL3 | Encodes essential myosin light chain | Supports myosin function and sarcomere integrity |
| TPM1 | Encodes alpha-tropomyosin, regulates thin filament function | Mutations associated with cardiomyopathy |
| TNNI3 | Encodes cardiac troponin I, inhibits actomyosin ATPase | Variants affect sarcomere regulation and disease |
| ACTN2 | Encodes alpha-actinin-2, a Z-disc component | Important for Z-disc formation and sarcomere alignment |
| DES | Encodes desmin, an intermediate filament protein linking sarcomeres | Supports sarcomere organization and cytoskeletal integration |
| NEB | Encodes nebulin, regulates thin filament length in skeletal muscle | Contributes to sarcomere organization in skeletal muscle |
| MYOZ2 | Encodes myozenin-2, a Z-disc protein | Involved in sarcomere assembly and signaling |
| CSRP3 | Encodes muscle LIM protein, a Z-disc component | Links sarcomere organization to mechanotransduction |
| BAG3 | Encodes BAG family molecular chaperone regulator 3 | Supports sarcomeric protein quality control |
| SUMO1 | Small ubiquitin-like modifier 1, modifies sarcomeric proteins | Regulates sarcomere organization via SUMOylation |
| UBC9 | SUMO-conjugating enzyme UBC9 | Mediates SUMOylation of sarcomeric proteins |
How Is sarcomere organization Regulated?
Sarcomere organization is regulated at multiple levels. The SUMO system, including SUMO1 and the conjugating enzyme UBC9, modifies sarcomeric proteins and controls their stability and assembly, making it a key regulator of sarcomere organization. Post-translational modifications such as phosphorylation also influence sarcomere assembly and function, as shown by CaMKII activation upon FHOD3 deficiency. Metabolic and mechanical cues, such as those present in severe obesity, can alter contractile protein function and organization in human heart failure with preserved ejection fraction. Additionally, developmental maturation programs promote sarcomere organization in human pluripotent stem cell-derived cardiac tissue.
sarcomere organization and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| MYH7 | Hypertrophic cardiomyopathy | Knockout or point-mutation in human iPSC-derived cardiomyocytes |
| MYBPC3 | Hypertrophic cardiomyopathy | Knock-in of patient variants in iPSC-derived cardiomyocytes |
| FHOD3 | Sarcomere disorganization and CaMKII activation | Knockout in human stem cell-derived cardiomyocytes |
| TTN | Sarcomere organization and cardiomyopathy | Knock-in of truncating variants in iPSC-derived cardiomyocytes |
| SUMO1 | Regulation of sarcomere organization | Overexpression or knockout in cardiomyocytes |
Hypertrophic cardiomyopathy
Multiple rare variants in sarcomere genes have malignant effects on the prognosis of patients with hypertrophic cardiomyopathy, and these variants often impair sarcomere organization. Genes such as MYH7, MYBPC3, TNNT2, and ACTC1 are frequently implicated, and their mutations can lead to disorganized sarcomeres, compensatory hypertrophy, and increased risk of heart failure.
Heart failure with preserved ejection fraction (HFpEF)
Severe obesity in human HFpEF alters contractile protein function and organization, linking metabolic stress to sarcomere disorganization. This suggests that sarcomere organization is not only affected by genetic mutations but also by acquired metabolic conditions, and it may be a therapeutic target in HFpEF.
Arrhythmogenesis
Flexible nanoelectronics have revealed arrhythmogenesis in transplanted human cardiomyocytes, where abnormal sarcomere organization and electrical coupling contribute to arrhythmias. This highlights the importance of sarcomere organization for normal electrical function and the potential for engineered tissues to model arrhythmia mechanisms.
FHOD3-related cardiomyopathy
FHOD3 deficiency disrupts sarcomere organization and activates CaMKII signaling in human stem cell-derived cardiomyocytes, providing a direct link between a formin family gene and sarcomere assembly defects. This model demonstrates how loss-of-function of a sarcomere-associated gene can trigger pathological signaling.
From sarcomere organization-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of a candidate gene disrupt sarcomere organization? | CRISPR knockout in human iPSC-derived cardiomyocytes |
| Do patient-specific point mutations cause sarcomere defects? | CRISPR point-mutation knock-in in iPSC-derived cardiomyocytes |
| Does a specific protein tag affect sarcomere assembly? | Tagged knock-in of sarcomeric proteins in cardiomyocytes |
| Does overexpression of a sarcomere gene rescue organization? | Overexpression in human stem cell-derived cardiomyocytes |
| How does SUMOylation regulate sarcomere organization? | Knockout or overexpression of SUMO1/UBC9 in cardiomyocytes |
| Can sarcomere organization be restored by pharmacological intervention? | Patient-derived iPSC cardiomyocytes treated with modulators |
How to Study the sarcomere organization Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Fluorescence microscopy | Sarcomere alignment and Z-disc periodicity | Assessing organization in edited cardiomyocytes |
| Electron microscopy | Ultrastructure of thick and thin filaments | Validating sarcomere assembly defects |
| RNA sequencing | Expression of sarcomeric genes | Profiling transcriptional changes in disease models |
| Proteomics | Protein abundance and modifications | Identifying SUMOylated sarcomeric proteins |
| Traction force microscopy | Contractile force generation | Functional readout of sarcomere organization |
| Calcium imaging | Calcium handling and arrhythmogenesis | Linking sarcomere organization to electrical function |
| CRISPR screens | Genes required for sarcomere organization | Discovery of novel regulators |
| Flexible nanoelectronics | Electrophysiological activity | Detecting arrhythmias in transplanted cardiomyocytes |
Imaging-based assessment of sarcomere organization
High-resolution fluorescence and electron microscopy are used to visualize sarcomere alignment and Z-disc periodicity in cardiomyocytes. Advanced maturation of human cardiac tissue from pluripotent stem cells enables imaging of organized sarcomeres in vitro. Flexible nanoelectronics can also record electrical activity in parallel with structural assessment.
Transcriptomic and proteomic profiling
RNA sequencing and proteomics can quantify expression of sarcomeric genes and identify changes in protein abundance or modifications that accompany sarcomere organization. These approaches help link genetic variants to downstream effects on sarcomere assembly.
Functional contractility assays
Contractility measurements, such as traction force microscopy or calcium imaging, assess the functional consequences of sarcomere organization. These assays are used to determine whether genetic or pharmacological interventions improve or impair contractile function.
CRISPR-based genetic screens
Pooled CRISPR screens can identify genes required for sarcomere organization by selecting for cells with normal or abnormal sarcomere structure. Such screens have the potential to uncover novel regulators of GO:0045214.
How CRISPR Can Be Used to Study GO:0045214 sarcomere organization
Knockout
CRISPR knockout of sarcomere genes such as FHOD3 in human stem cell-derived cardiomyocytes disrupts sarcomere organization and activates CaMKII signaling, providing causal evidence for gene function. Knockout models are essential for determining whether a candidate gene is required for sarcomere assembly.
Point Mutation
CRISPR point-mutation knock-in can introduce patient-specific variants in sarcomere genes like MYH7 or MYBPC3 to test their effects on sarcomere organization and contractility. Such models help distinguish pathogenic variants from benign polymorphisms.
Knock-in
Knock-in of tagged sarcomeric proteins, such as fluorescently labeled titin or myosin, allows live-cell imaging of sarcomere assembly and dynamics. This approach is valuable for tracking the incorporation of proteins into newly forming sarcomeres.
Overexpression
Overexpression of sarcomere genes or regulators like SUMO1 can rescue or enhance sarcomere organization in disease models. Overexpression studies help identify sufficiency of a gene to drive sarcomere assembly.
How EDITGENE Supports sarcomere organization Research
Researchers studying sarcomere organization-related genes often need to determine whether a candidate gene is causally involved in sarcomere assembly, how specific mutations affect protein function, and whether restoring gene activity can rescue organization. EDITGENE provides a comprehensive suite of CRISPR services to address these questions in relevant cell models.
Contact EDITGENE today to design your custom CRISPR model for sarcomere organization research.
Frequently Asked Questions About sarcomere organization
What is GO:0045214 sarcomere organization?
GO:0045214 is the biological process that assembles muscle actomyosin into sarcomeres, the repeating contractile units of a myofibril, as defined by QuickGO.
What genes are involved in sarcomere organization?
Key genes include MYH7, MYBPC3, TNNT2, ACTC1, FHOD3, TTN, and SUMO1, among others.
Why is sarcomere organization important?
It determines the contractile capacity of muscle and its disruption causes cardiomyopathy, heart failure, and arrhythmias.
How is sarcomere organization regulated?
It is regulated by post-translational modifications such as SUMOylation and by signaling pathways including CaMKII.
What diseases are linked to defective sarcomere organization?
Hypertrophic cardiomyopathy, heart failure with preserved ejection fraction, and arrhythmogenesis are linked to defects in sarcomere organization.
How can I study sarcomere organization in the lab?
Common methods include fluorescence microscopy, electron microscopy, contractility assays, and CRISPR screens in human iPSC-derived cardiomyocytes.
What is the role of FHOD3 in sarcomere organization?
FHOD3 deficiency disrupts sarcomere organization and activates CaMKII signaling in human stem cell-derived cardiomyocytes.
How does SUMOylation affect sarcomere organization?
The SUMO system regulates the stability and assembly of sarcomeric proteins, making it a key regulator of sarcomere organization.
Can CRISPR be used to model sarcomere organization diseases?
Yes, CRISPR knockout, point-mutation, knock-in, and overexpression models in cardiomyocytes are widely used to study sarcomere organization.
What cell models are best for studying sarcomere organization?
Human induced pluripotent stem cell-derived cardiomyocytes are a powerful model because they can be genetically edited and matured to display organized sarcomeres.
Conclusion
Sarcomere organization (GO:0045214) is a fundamental biological process that builds the contractile machinery of muscle cells. Its precise regulation by sarcomeric proteins, post-translational modifiers, and signaling pathways is essential for normal muscle function, and its disruption underlies major cardiac diseases. Advances in human stem cell-derived cardiomyocyte models and CRISPR genome editing now allow researchers to dissect the causal roles of individual genes and variants in sarcomere organization. Continued investigation of GO:0045214 will inform new therapeutic strategies for cardiomyopathy and heart failure.
References
- 1. Nayak A et al.. 2020. SUMO system - a key regulator in sarcomere organization.. FEBS J 287(11):2176-2190 PMID: 32096922
- 2. Sweeney HL et al.. 2018. Muscle Contraction.. Cold Spring Harb Perspect Biol 10(2) PMID: 29419405
- 3. Wang J et al.. 2014. Malignant effects of multiple rare variants in sarcomere genes on the prognosis of patients with hypertrophic cardiomyopathy.. Eur J Heart Fail 16(9):950-7 PMID: 25132132
- 4. Ronaldson-Bouchard K et al.. 2018. Advanced maturation of human cardiac tissue grown from pluripotent stem cells.. Nature 556(7700):239-243 PMID: 29618819
- 5. Jani VP et al.. 2026. Severe obesity in human HFpEF alters contractile protein function and organization.. Science 392(6802):eadz7118 PMID: 42024776
- 6. Aoyama J et al.. 2025. Flexible nanoelectronics reveal arrhythmogenesis in transplanted human cardiomyocytes.. Science 390(6774):eadw4612 PMID: 41100583
- 7. Wei M et al.. 2026. FHOD3 deficiency disrupts sarcomere organization and activates caMKII signaling in human stem cell-derived cardiomyocytes.. Stem Cell Res Ther 17(1):82 PMID: 41540467
- 8. Wang Z et al.. 2021. The molecular basis for sarcomere organization in vertebrate skeletal muscle.. Cell 184(8):2135-2150.e13 PMID: 33765442
